Fig. 3
From: Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
Comparison of baseline eGFR and latest eGFR by baseline eGFR. A) Group H (high eGFR, n = 6): eGFR changes from 106.0 mL/min/1.73 m2 to 86.1 mL/min/1.73 m2, for a mean difference of −20.0 mL/min/1.73 m2 (p = 0.0228). B) Group M (middle eGFR, n = 26): eGFR changes from 73.8 mL/min/1.73 m2 to 64.0 mL/min/1.73 m2, for a mean difference of − 9.7 mL/min/1.73 m2 (p = 0.0546). C) Group L (low eGFR, n = 8): eGFR changes from 50.4 mL/min/1.73 m2 to 51.3 mL/min/1.73 m2, for a mean difference of 0.9 mL/min/1.73 m2 (p = 0.8354)